3 ms·
"In May 2007 the company pleaded guilty to misleading the public about Oxycontin's risk of addiction and agreed to pay $600 million in one of the largest pharma
by mcguire 9y ago
"In May 2007 the company pleaded guilty to misleading the public about Oxycontin's risk of addiction and agreed to pay $600 million in one of the largest pharmaceutical settlements in U.S. history. Its president, top lawyer and former chief medical officer pleaded guilty as individuals to misbranding charges, a criminal violation and agreed to pay a total of $34.5 million in fines. Those executives are: Michael Friedman, the company’s president, who agreed to pay $19 million in fines; Howard R. Udell, its top lawyer, who agreed to pay $8 million; and Dr. Paul D. Goldenheim, its former medical director, who agreed to pay $7.5 million.
"In addition three top executives were charged with a felony and sentenced to 400 hours of community service in drug treatment programs."
https://en.wikipedia.org/wiki/Purdue_Pharma?wprov=sfla1 https://en.wikipedia.org/wiki/Purdue_Pharma?wprov=sfla1
I wouldn't really consider them a scapegoat.
"As shown in Figure 1A, the selection of OxyContin as a primary drug of abuse decreased from 35.6% of respondents before the release of the abuse-deterrent formulation to just 12.8% 21 months later (P<0.001). Simultaneously, selection of hydrocodone and other oxycodone agents increased slightly, whereas for other opioids, including high-potency fentanyl and hydromorphone, selection rose markedly, from 20.1% to 32.3% (P=0.005). Of all opioids used to “get high in the past 30 days at least once” (Figure 1B), OxyContin fell from 47.4% of respondents to 30.0% (P<0.001), whereas heroin use nearly doubled."
http://www.nejm.org/doi/full/10.1056/NEJMc1204141 http://www.nejm.org/doi/full/10.1056/NEJMc1204141
The abuse-resistant version had some unhappy consequences.
"Available data indicate that the nonmedical use of prescription opioids is a strong risk factor for heroin use. Yet, although the majority of current heroin users report having used prescription opioids nonmedically before they initiated heroin use, heroin use among people who use prescription opioids for nonmedical reasons is rare, and the transition to heroin use appears to occur at a low rate."
http://www.nejm.org/doi/full/10.1056/NEJMra1508490#conclusions http://www.nejm.org/doi/full/10.1056/NEJMra1508490#conclusio...
Of course, the issue here is not that oxycontin is a gateway drug, but that prescription opioids are being abused, and Purdue and oxycontin are undoubtedly at the forefront of that.